financetom
Business
financetom
/
Business
/
Defence firm QinetiQ warns of delays in UK, US contracts being awarded
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Defence firm QinetiQ warns of delays in UK, US contracts being awarded
Mar 17, 2025 4:23 AM

(Reuters) - British defence and security company QinetiQ on Monday warned of delays in short-term contracts being awarded in the U.S. and UK, where new policies are being implemented after recent changes in government.

Shares in the company, which develops and tests systems used across the defence, space, government and other sectors, fell as much as 20% and are on track for their worst day on record after QinetiQ said the delays would affect its revenues.

The company forecast organic revenue growth of just about 2% for the year ending March 31, with underlying margins of roughly 10%. That compares with growth of 14% and 16% respectively in the previous fiscal year. 

For fiscal 2026, growth is expected to improve slightly to about 3-5% and 11-12%, QinetiQ said. 

In the U.S., President Donald Trump has created a new Department of Government Efficiency to look at extensive cuts to federal bureaucracy and "maximize governmental efficiency and productivity", under tech billionaire Elon Musk's oversight.

U.S. contracts are recorded by QinetiQ in its Global Solutions unit, which accounts for roughly a quarter of overall revenues at the company. It is also restructuring its U.S. business, expecting to take a charge of 140 million pounds ($181.3 million) at year-end.

QinetiQ's EMEA services and UK defence unit make up nearly half of all revenues. That business is performing strongly as it largely has longer-duration contracts, the company said.

However, UK Intelligence, which makes up for the rest of revenues, has experienced delays in contracts of shorter duration.

British finance minister Rachel Reeves, part of the Labour government that took office last July, said earlier this month she would speed up defence procurement, but the industry is waiting for more clarity on government spending priorities in a review expected this Spring.

Britain last month announced an increase in military spending in response to Trump's call for Europe to do more to protect itself amid rising geopolitical tensions.

($1 = 0.7721 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InterRent Declares Monthly Distribution, Suspends Distribution Reinvestment Plan
InterRent Declares Monthly Distribution, Suspends Distribution Reinvestment Plan
Dec 16, 2024
09:01 AM EST, 12/16/2024 (MT Newswires) -- InterRent Real Estate Investment Trust (IIP-UN) on Monday said it will pay a monthly distribution of $0.0331 per trust unit, the same amount as the prior month. The payment will be made on or about Jan. 15, to unitholders of record on Dec. 31. The company also said its plan to suspend the...
CareCloud Names Stephen Snyder as CO-CEO Alongside A. Hadi Chaudhry
CareCloud Names Stephen Snyder as CO-CEO Alongside A. Hadi Chaudhry
Dec 16, 2024
09:05 AM EST, 12/16/2024 (MT Newswires) -- CareCloud ( CCLD ) said Monday that Stephen Snyder will serve as co-chief executive officer alongside current CEO A. Hadi Chaudhry, effective Jan. 1. The company also named Crystal Williams as president. Chaudhry will oversee technology and artificial intelligence strategies, while Snyder will lead growth efforts, including market expansion and partnerships, CareCloud (...
Senti Biosciences Reports First Patient Dosed in Trial of SN301A in Hepatocellular Carcinoma
Senti Biosciences Reports First Patient Dosed in Trial of SN301A in Hepatocellular Carcinoma
Dec 16, 2024
09:05 AM EST, 12/16/2024 (MT Newswires) -- Senti Biosciences ( SNTI ) said Monday that the first patient has been dosed in the pilot trial of SN301A to treat hepatocellular carcinoma. The biotech firm said the trial, which is taking place in mainland China, is part of a collaboration with Celest Therapeutics. Senti Bio said the two companies have the...
Skeena Resources Gets Regulatory Approval for Bulk Technical Sample at Eskay Creek Project
Skeena Resources Gets Regulatory Approval for Bulk Technical Sample at Eskay Creek Project
Dec 16, 2024
09:01 AM EST, 12/16/2024 (MT Newswires) -- Skeena Resources ( SKE ) said Monday that it has received approval from the British Columbia Ministry of Mining and Critical Minerals to extract 10,000-tonne bulk sample at the Eskay Creek gold-silver project. The bulk technical sample permit was a key requirement for the release of $200 million in gold stream project financing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved